NATURAL HOLISTIC MEDICINE BLOG - KINGSTON, R.I. — Aug. 20, 2026 — As scientific evidence regarding alcohol consumption and cancer risks continues to evolve, understanding how healthcare providers communicate these risks to patients has become a critical public health priority. Researchers at the University of Rhode Island College of Nursing have launched a groundbreaking study to evaluate how physicians and nurse practitioners navigate the complex relationship between alcohol use and breast cancer risk.
The initiative, officially titled the Breast Cancer Screening & Moderation of Alcohol for Risk Transformation (B-SMART) study, addresses a growing gap between clinical guidelines and everyday medical practice. Led by URI nursing Associate Dean for Research and Scholarship Patricia Cioe and Assistant Professor Erica Liebermann, the research project seeks to identify the barriers practitioners face when discussing alcohol-related health risks with female patients.
Understanding the Scope of the B-SMART Initiative
The primary objective of the B-SMART study is to assess the knowledge, clinical attitudes, and current counseling practices of healthcare professionals across Rhode Island. Researchers aim to gather detailed insights into whether providers feel adequately trained to discuss risk reduction strategies during routine clinical encounters.
To collect qualitative data, Cioe and Liebermann are conducting comprehensive online interviews via Zoom with participating primary care providers and specialists. These structured sessions prompt clinicians to reflect on their clinical perceptions, the specific advice they provide to patients, and potential digital or educational resources that could enhance patient counseling.
“We are hoping to understand healthcare providers’ perspectives on the importance of alcohol use in breast cancer development and risk, and the level of knowledge that healthcare providers have regarding the association,” said Associate Dean Patricia Cioe. “We’re hoping to understand what they share with patients about that risk, and whether or not they feel a need for further education on the subject.”
The Catalyst: Personal Insights and Collaborative Foundations
The concept for the B-SMART project originated during Cioe’s ongoing work with a research team at the Brown University School of Public Health, where she serves as an adjunct professor. That working group originally focused on evaluating patient awareness among women attending routine mammography screenings to determine their willingness to alter lifestyle habits.
However, a routine visit to Cioe's own healthcare provider transformed the direction of the inquiry toward the clinical side of the conversation. When Cioe asked her provider about the connection between moderate alcohol intake and breast cancer risk, the provider expressed little concern and admitted to rarely discussing the topic with patients.
“I just happened to ask my healthcare provider their perspective regarding alcohol and breast cancer, and found my provider was not very concerned and said they did not talk with their patients about it,” Cioe stated. “That led me to think that in addition to looking at what could be done from the patient’s perspective, we should think about the perspectives of healthcare providers around the state—what advice they give to patients, and whether they would be interested in additional education related to counseling patients about alcohol use.”
Navigating Shifting Public Health Guidelines
Translating medical evidence into clear patient guidance remains challenging due to historical variations in official public health recommendations. For years, guidelines from organizations such as the National Institute on Alcohol Abuse and Alcoholism (NIAAA) suggested that consuming up to one standard drink per day for women and two for men represented a low-risk threshold.
Contrasting sharply with older advice, recent reports from the U.S. Surgeon General and international health authorities emphasize that no level of alcohol consumption can be considered entirely safe regarding oncological risk. Epidemiological studies demonstrate that even light-to-moderate daily drinking incrementally increases a woman's lifetime probability of developing breast cancer.
The biological mechanisms connecting alcohol to breast malignancy involve elevated estrogen levels, DNA damage from acetaldehyde metabolites, and altered nutrient absorption. Because these physiological impacts occur even at minimal exposure levels, clear messaging from medical professionals is essential for patient decision-making.
Overcoming Clinical Communication Barriers
For primary care providers and nurse practitioners, keeping pace with rapidly updating epidemiological consensus requires continuous education. Furthermore, explaining changing guidelines to patients who may feel skeptical or overwhelmed presents a distinct interpersonal hurdle in fast-paced clinical settings.
Erica Liebermann, an assistant professor, board-certified nurse practitioner, and specialist in women’s health, highlighted the systemic friction clinicians face when attempting to address behavioral risk factors. She noted that lack of clinical discussion often stems from inadequate counseling tools rather than practitioner disinterest.
“Practitioners are accustomed to emerging, shifting evidence. But it does challenge us to keep up with that information,” explained Liebermann. “We need to fully digest it, and then convey that to patients, who are sometimes less comfortable with the fluctuations in guidelines. I think there is a degree to which newer information in terms of risk is not talked about. There may be limited awareness among practitioners of the association, but I think it probably has more to do with practitioners not feeling inclined or equipped to talk to patients about it.”
Study Recruitment and Long-Term Educational Goals
The research team is actively recruiting 20 to 25 physicians and nurse practitioners practicing throughout Rhode Island to participate in the qualitative Zoom interviews. Participating clinicians contribute directly to shaping future clinical interventions and educational frameworks designed to improve preventive healthcare delivery.
Interested healthcare professionals can access recruitment details through the official URI research portal or by contacting the study coordinators directly at projectBSMART2026@gmail.com. The gathered feedback will directly inform targeted training modules tailored to busy medical practice environments.
Ultimately, the researchers view the B-SMART project as the foundation for a broader, long-term scientific program aimed at lowering breast cancer incidence through informed lifestyle choices. By equipping providers with practical communication tools, the team hopes to empower patients across Rhode Island to make proactive choices regarding their long-term health.
“This is our first step in developing a line of research,” Cioe emphasized. “This is information gathering to better understand the issue, with the goal of potentially developing an educational program for healthcare providers and for patients. This is a step in that direction.”
Frequently Asked Questions (FAQ)
What is the primary goal of the URI B-SMART study?
The Breast Cancer Screening & Moderation of Alcohol for Risk Transformation (B-SMART) study aims to evaluate healthcare providers' understanding of the link between alcohol use and breast cancer risk, while identifying barriers to effective clinician-patient communication.
Who is leading the B-SMART research project at the University of Rhode Island?
The study is led by Patricia Cioe, URI nursing Associate Dean for Research and Scholarship, and Erica Liebermann, Assistant Professor and nurse practitioner specializing in women's health.
How does alcohol consumption impact breast cancer risk in women?
Scientific research shows that alcohol increases estrogen levels and releases acetaldehyde metabolites, which can damage cell DNA and elevate breast cancer risk even at low levels of intake, such as one drink per day.
How are researchers gathering data from medical practitioners?
Researchers are recruiting 20 to 25 physicians and nurse practitioners across Rhode Island to participate in detailed, one-on-one qualitative interviews conducted via Zoom.
How can healthcare providers in Rhode Island participate in the B-SMART study?
Interested physicians and nurse practitioners can sign up via the official research website or contact the research team via email at projectBSMART2026@gmail.com.
Comments